Results of the phase 3 ELOQUENT-2 trial
26 Jun 2015 Oncology

Results of the phase 3 PERSIST-1 trial of pacritinib for myelofibrosis
26 Jun 2015 Oncology

Results of the phase 2 54767414MMY2002 (Sirius) trial of daratumumab for multiple myeloma
26 Jun 2015 Oncology

DNMT3A R882 mutations in AML promote chemoresistance and therapeutic relapse
26 Jun 2015 Oncology

Updated results from the SORAML trial of sorafenib in younger patients with newly diagnosed AML
26 Jun 2015 Oncology

The crucial roles of GFI1B in platelet development
26 Jun 2015 Hematology

Pacritinib therapy led to symptom improvement in myelofibrosis
26 Jun 2015 Hematology

Treatment and outcome of CML patients from the EUTOS population-based registry
26 Jun 2015 Hematology

Venetoclax (ABT-199/GDC-0199) plus rituximab shows promise in relapsed/refractory CLL
26 Jun 2015 Hematology

Adding elotuzumab to standard treatment for myeloma reduced disease progression
26 Jun 2015 Hematology

Phase 3 CheckMate 067 trial of nivolumab in previously untreated advanced melanoma
26 Jun 2015 Oncology

Whole Brain Radiation Therapy is More Harmful Than Beneficial for Small Brain Metastases
26 Jun 2015 Oncology

Elective Neck Dissection Improved Survival in Early Node-Negative Oral Cancer
26 Jun 2015 Oncology

Improved Cancer Treatments Linked to Reduced Late Mortality in Childhood Cancer Survivors
26 Jun 2015 Oncology

Combined Nivolumab and Ipilimumab or Monotherapy Shown Promise in Untreated Melanoma
26 Jun 2015 Oncology

Novel JAK Inhibitor Pacritinib Proves Effective for Easing Symptoms of Myelofibrosis
26 Jun 2015 Oncology

Obinutuzumab Doubles Remission Duration in Relapsed, Indolent Non-Hodgkin Lymphoma
26 Jun 2015 Oncology

Daratumumab Shows Promise in Heavily Treatment-Resistant Multiple Myeloma
26 Jun 2015 Oncology

New Ibrutinib Combination Regimen Shows Substantial Benefits in Relapsed CLL
26 Jun 2015 Oncology

Dr A. Erdem Canda Chairs a Discussion on the Trends and Developments in the Field of Endourology
25 Jun 2015 Nephrology

An Interview with Dr. Abolfazl Hosseni at the 11th National Endourology Congress, Discussing the Developing Treatment in Bladder Cancer
25 Jun 2015 Urology

An Interview with Dr. Abhay Rane at the 11th National Endourology Congress, Discussing the Key Points of the Upcoming World Congess of Endourology
25 Jun 2015 Urology

An Interview with Dr. John W. Davis at the 11th National Endourology Congress, Discussing the Key Points from the Congress
25 Jun 2015 Urology

An Interview with Dr. Kevin C. Zorn at the 11th National Endourology Congress, Discussing Developments within the Field
25 Jun 2015 Urology

Nivolumab Shows Highly Promising Activity in Advanced Liver Cancer in Early-Stage Trial
02 Jun 2015 Urology

Genomic Marker Predicts Anti-PD-1 Response in Several Cancers
02 Jun 2015 Oncology

Nivolumab Extends Survival for Patients With the Most Common Lung Cancer
02 Jun 2015 Oncology

An introduction to ASCO 2015 by the 2014-15 president, Peter Paul Yu, MD, FACP, FASCO
02 Jun 2015 Oncology